Date published: 2025-10-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

Tachykinin Inhibitors

Santa Cruz Biotechnology now offers a broad range of Tachykinin Inhibitors for use in various applications. Tachykinin inhibitors are pivotal in neurobiological research due to their role in modulating neurotransmitters and neuromodulators involved in the transmission of nerve impulses, particularly in the central and peripheral nervous systems. These compounds are essential tools for scientists exploring the intricate mechanisms of neurogenic inflammation, pain transmission, and mood regulation. Their utility extends to neurophysiological studies, where understanding the pathways of substance P and other tachykinins provides insights into nervous system disorders and their underlying molecular dynamics. By inhibiting the action of these peptides, researchers can study altered neurotransmission in a controlled environment, enabling the exploration of nerve response and recovery mechanisms without the interference of endogenous tachykinins. Furthermore, tachykinin inhibitors are instrumental in explaining the roles of these peptides in animal models, which are often designed to mimic human neurological conditions, thereby offering a crucial window into potential mechanisms that can disrupt or modify pathological signaling pathways. This research sheds light on fundamental biological processes that could inform a myriad of applications, such as the development of bioassays for neurological research or the creation of new diagnostic tools. View detailed information on our available Tachykinin Inhibitors by clicking on the product name.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

MDL 105,212 hydrochloride

167261-59-8sc-221877
sc-221877A
1 mg
5 mg
$90.00
$286.00
(0)

MDL 105,212 hydrochloride is a potent tachykinin receptor antagonist that exhibits high affinity for neurokinin receptors, particularly NK1. Its unique structural conformation enables it to effectively disrupt receptor-ligand interactions, modulating downstream signaling pathways. The compound's interaction kinetics reveal a competitive binding mechanism, allowing for precise regulation of receptor activity. Additionally, its solubility properties enhance its bioavailability in various environments, influencing its overall efficacy in biological systems.

SB 222200

174635-69-9sc-224282
sc-224282A
10 mg
50 mg
$205.00
$800.00
1
(0)

SB 222200 is a selective tachykinin receptor antagonist that demonstrates a unique ability to modulate neurokinin signaling. Its distinct molecular architecture facilitates strong interactions with specific receptor sites, leading to altered conformational states that inhibit receptor activation. The compound exhibits rapid binding kinetics, allowing for swift modulation of tachykinin pathways. Furthermore, its stability in diverse conditions enhances its potential for targeted applications in various biochemical contexts.